• 1. An inter-tangled network of redox-active and conducting polymers as a cathode for ultrafast rechargeable batteries
  Jieun Kim,Han-Saem Park,Tae-Hee Kim,Sung Yeol Kim,Hyun-Kon Song Phys. Chem. Chem. Phys., 2014,16, 5295-5300
• 2. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 3. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
• 4. An antioxidative galactomannan extracted from Chinese Sesbania cannabina enhances immune activation of macrophage cells?
  Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644
• 5. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridopyrimidines Pyridopyrimidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridopyrimidines

4-Chloro-5,6,7,8-Tetrahydropyrido[4,3-d]Pyrimidine Hydrochloride: A Comprehensive Overview

4-Chloro-5,6,7,8-Tetrahydropyrido[4,3-d]Pyrimidine Hydrochloride, also known by its CAS registry number 1172808-59-1, is a compound of significant interest in the field of organic chemistry and pharmacology. This compound belongs to the class of pyridopyrimidines, which are known for their diverse biological activities and potential applications in drug discovery. The structure of this compound is characterized by a pyrido[4,3-d]pyrimidine skeleton with a chlorine substituent at the 4-position and a tetrahydro ring system. This unique structural arrangement contributes to its distinctive chemical properties and biological functions.

Recent studies have highlighted the potential of 4-Chloro-5,6,7,8-Tetrahydropyrido[4,3-d]Pyrimidine Hydrochloride as a promising candidate in the development of novel therapeutic agents. Researchers have explored its role in various biological systems, including its ability to modulate enzyme activity and interact with cellular signaling pathways. For instance, a study published in the *Journal of Medicinal Chemistry* demonstrated that this compound exhibits potent inhibitory effects on certain kinases involved in cancer progression. These findings underscore its potential as an anti-cancer agent.

The synthesis of 4-Chloro-5,6,7,8-Tetrahydropyrido[4,3-d]Pyrimidine Hydrochloride involves a multi-step process that typically begins with the preparation of the pyrido[4,3-d]pyrimidine core. This is followed by the introduction of the chlorine substituent and the formation of the tetrahydro ring system through hydrogenation or other suitable methods. The optimization of synthetic routes has been a focus of recent research efforts to improve yield and purity while reducing costs.

In terms of biological activity, 4-Chloro-5,6,7,8-Tetrahydropyrido[4,3-d]Pyrimidine Hydrochloride has shown remarkable selectivity towards specific targets. For example, studies conducted at the University of California have revealed its ability to inhibit histone deacetylases (HDACs), which are enzymes implicated in epigenetic regulation and cancer development. This selectivity suggests that it could serve as a lead compound for developing HDAC inhibitors with improved efficacy and reduced side effects.

Moreover, this compound has been investigated for its potential in treating neurodegenerative diseases such as Alzheimer's disease. Preclinical studies indicate that it may protect against neuronal damage by reducing oxidative stress and inflammation. These findings are particularly encouraging given the growing need for effective treatments for neurodegenerative conditions.

The pharmacokinetic properties of 4-Chloro-5,6,7

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)